← All trials
NCT06975319
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 29, 2025
- Primary completion
- Dec 2, 2025
- Completion date
- Jul 30, 2026
- First posted
- May 16, 2025
- Last posted
- Aug 26, 2025
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- VirometixLead sponsor
- Ghent UniversityOfficial
- CR2OCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.